The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Hereditary Elliptocytosis: Genetic Membrane Disorder Management

Inherited red cell membrane defect with elliptical red cell morphology and variable clinical severity

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Hereditary Elliptocytosis: Genetic Membrane Disorder Management?

Hereditary elliptocytosis is most commonly an autosomal dominant disorder of red cell membrane skeleton with elliptical morphology of mature erythrocytes.

Genetic defects involve spectrin (alpha and beta), protein 4.1 and glycophorin C with various mutations affecting horizontal interactions of membrane skeleton.

Clinical spectrum ranges from asymptomatic hereditary elliptocytosis (most common) to severe hereditary pyropoikilocytosis presenting in infancy.

Hereditary pyropoikilocytosis represents a severe form often with double heterozygosity or homozygosity for spectrin defects.

Diagnosis combines characteristic peripheral blood smear (greater than 25 percent elliptocytes), family history and genetic testing in selected cases.

Symptoms

Asymptomatic with normal hemoglobin in approximately 90 percent of cases discovered incidentally on blood smear.
Mild compensated hemolysis with mild anemia, slight reticulocytosis and elevated indirect bilirubin.
Severe hemolytic anemia in hereditary pyropoikilocytosis with marked anemia, bizarre red cell morphology and microcytosis.
Splenomegaly may develop in symptomatic forms with chronic hemolysis.
Pigmented gallstones and cholecystitis from chronic hemolysis in long-standing disease.

Risk Factors

Family history of hereditary elliptocytosis or hereditary pyropoikilocytosis.
Specific ethnic populations including Mediterranean, African and Asian populations have higher prevalence.
Co-inheritance of additional red cell membrane defects amplifies clinical severity.
Pregnancy may transiently worsen hemolysis in some affected individuals.
No environmental or lifestyle risk factors as this is genetically determined.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Family history of hereditary elliptocytosis warrants screening particularly for pregnancy planning and counseling purposes.
  • Newborn with severe hemolytic anemia, hyperbilirubinemia or characteristic red cell morphology requires hematology evaluation for hereditary pyropoikilocytosis.
  • Symptomatic hemolysis with anemia, jaundice or splenomegaly in any age group needs hematology referral.
  • Pigmented gallstones in young patient with mild anemia warrants evaluation for chronic hemolysis.
  • Lifelong monitoring with periodic hematologic assessment guides management decisions and detects complications.

Treatment Methods

01
Asymptomatic patients require no specific treatment beyond genetic counseling and family screening.
02
Folate supplementation in patients with chronic hemolysis to support increased red cell production.
03
Splenectomy is therapeutic in symptomatic patients with severe hemolysis improving anemia though does not correct underlying membrane defect.
04
Cholecystectomy with splenectomy in patients with concurrent gallstones to prevent future biliary complications.
05
Comprehensive care including genetic counseling, family screening, monitoring for complications including aplastic crises with parvovirus infection, prophylactic vaccinations after splenectomy and supportive care for hereditary pyropoikilocytosis with red cell transfusions and exchange transfusion in neonates optimize lifelong management.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Hereditary Elliptocytosis

Hematoloji

Hereditary elliptocytosis is an inherited disorder of red blood cell membrane skeleton, producing elliptical erythrocytes and a wide spectrum of clinical phenotypes from asymptomatic to severe hemolysis.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.